tiprankstipranks
Central China New Life Ltd. (HK:9983)
:9983
Hong Kong Market
Want to see HK:9983 full AI Analyst Report?

Central China New Life Ltd. (9983) AI Stock Analysis

2 Followers

Top Page

HK:9983

Central China New Life Ltd.

(9983)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
HK$0.55
▼(-7.83% Downside)
Action:Reiterated
Date:05/13/26
The score is driven by a highly discounted valuation (very low P/E and very high dividend yield) and a strong, low-debt balance sheet. These positives are offset by a significant deterioration in cash generation (deeply negative operating and free cash flow) and some near-term technical pullback risk due to overbought momentum and price still below the 200-day average.
Positive Factors
Conservative Balance Sheet
Extremely low debt provides durable financial flexibility: the company can absorb operating volatility, fund working capital or investments without immediate refinancing, and maintain policy choices (dividends, capex) longer than peers with higher leverage.
Negative Factors
Severe Cash-Flow Deficit
Deep negative operating and free cash flow materially weaken the firm's ability to fund operations and investments from internal resources. Over a multi-month horizon this raises funding risk, could force asset sales, external financing, or cuts to discretionary spending.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative Balance Sheet
Extremely low debt provides durable financial flexibility: the company can absorb operating volatility, fund working capital or investments without immediate refinancing, and maintain policy choices (dividends, capex) longer than peers with higher leverage.
Read all positive factors

Central China New Life Ltd. (9983) vs. iShares MSCI Hong Kong ETF (EWH)

Central China New Life Ltd. Business Overview & Revenue Model

Company Description
Central China New Life Limited, an investment holding company, provides property management services and value-added services in the People's Republic of China. It operates through three segments: Property Management and Value-Added Services, Life...
How the Company Makes Money
null...

Central China New Life Ltd. Financial Statement Overview

Summary
Balance sheet strength (very low leverage) is a major positive, and profitability recovered in 2025 after the 2023 loss year. However, cash flow is the key weakness with deeply negative operating and free cash flow in 2025, and 2025 revenue/margins weakened versus 2024—reducing confidence in earnings quality and near-term execution.
Income Statement
58
Neutral
Balance Sheet
82
Very Positive
Cash Flow
33
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.77B2.95B2.84B3.15B3.60B
Gross Profit543.95M652.77M757.09M1.04B1.18B
EBITDA273.51M396.59M-641.15M830.62M887.44M
Net Income157.48M214.59M-574.37M562.26M619.56M
Balance Sheet
Total Assets4.33B4.73B4.85B5.33B5.04B
Cash, Cash Equivalents and Short-Term Investments424.29M1.19B1.66B2.08B2.32B
Total Debt59.53M66.96M67.84M85.80M50.18M
Total Liabilities2.37B2.74B2.69B2.28B1.98B
Stockholders Equity1.89B1.86B2.05B2.94B2.95B
Cash Flow
Free Cash Flow-513.02M-4.53M-89.89M290.92M145.45M
Operating Cash Flow-510.28M3.86M-77.09M308.66M178.44M
Investing Cash Flow-115.40M893.00K18.46M126.84M245.64M
Financing Cash Flow-137.42M-429.37M-370.14M-675.63M-360.51M

Central China New Life Ltd. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.60
Price Trends
50DMA
0.40
Positive
100DMA
0.47
Negative
200DMA
0.71
Negative
Market Momentum
MACD
0.02
Negative
RSI
57.09
Neutral
STOCH
57.12
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9983, the sentiment is Neutral. The current price of 0.6 is above the 20-day moving average (MA) of 0.39, above the 50-day MA of 0.40, and below the 200-day MA of 0.71, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 57.09 is Neutral, neither overbought nor oversold. The STOCH value of 57.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:9983.

Central China New Life Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
HK$482.81M3.9811.59%1.82%-2.78%
67
Neutral
HK$571.62M3.978.29%18.38%-6.24%-27.19%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
55
Neutral
HK$306.80M11.110.55%7.40%10.87%
45
Neutral
HK$380.86M-1.26-12.36%-6.79%45.58%
45
Neutral
HK$449.92M-0.31-107.79%7.31%-4.07%-4882.20%
41
Neutral
HK$392.00M-1.432.68%-0.62%-220.23%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:9983
Central China New Life Ltd.
0.43
-0.72
-62.61%
HK:1778
Colour Life Services Group Co
0.16
0.00
0.00%
HK:2165
Ling Yue Services Group Limited
1.68
0.43
34.40%
HK:3913
KWG Living Group Holdings Limited
0.19
-0.11
-36.67%
HK:6093
Hevol Services Group Co. Limited
0.70
-0.64
-47.76%
HK:6677
Sino-Ocean Service Holding Ltd.
0.38
-0.11
-22.45%

Central China New Life Ltd. Corporate Events

Central China New Life Sets 2026 AGM, Seeks Mandate to Issue New Shares
Apr 20, 2026
Central China New Life Limited has called its annual general meeting for 1 June 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements and directors’ and auditors’ reports for the year ended 31 ...
Central China New Life Profit Falls as Margins Tighten in 2025
Mar 20, 2026
Central China New Life Limited reported a decline in performance for 2025, as revenue fell 6.2% year on year to RMB2,768.5 million and gross profit dropped 15.1% to RMB543.9 million, with gross margin narrowing to 19.6%. The company’s GFA un...
Central China New Life Warns of Profit Drop Amid Real Estate Downturn
Mar 13, 2026
Central China New Life Limited has warned that its unaudited consolidated net profit for 2025 is expected to fall by about 27% to 32% from RMB238.2 million in 2024, with profit attributable to shareholders projected to decline by roughly 25% to 30...
Central China New Life Sets March Board Meeting to Approve 2025 Results and Consider Dividend
Mar 10, 2026
Central China New Life Limited has scheduled a board meeting for 20 March 2026 to review and approve the annual results for the year ended 31 December 2025. The board will also consider whether to recommend a final dividend, a decision that could ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 13, 2026